The effects of vitamin D replacement on pathological complete response (pCR) in breast cancer patients receiving neoadjuvant systemic chemotherapy (NAC)

Complete Response ◽

Breast Cancer Patients

Tumor histological subtyping determined by hormone receptors and HER2 status defines different pathological complete response and outcome to dose-dense neoadjuvant chemotherapy in breast cancer patients

Clinical & Translational Oncology ◽

10.1007/s12094-013-1116-z ◽

2013 ◽

Vol 16 (6) ◽

pp. 548-554 ◽

Cited By ~ 6

Author(s):

A. Sánchez-Muñoz ◽

Y. Plata-Fernández ◽

M. Fernández ◽

A. Jaén-Morago ◽

M. Fernández-Navarro ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Hormone Receptors ◽

Complete Response ◽

Her2 Status ◽

Breast Cancer Patients ◽

Dose Dense

Impact of Ipsilateral Supraclavicular Lymph Node Dissection (ISLND) for Breast Cancer Patients and a Nomogram for Predicting Ipsilateral Supraclavicular Pathological Complete Response (ispCR)

Annals of Surgical Oncology ◽

10.1245/s10434-020-09548-6 ◽

2021 ◽

Author(s):

Minhao Lv ◽

Juntao Li ◽

Huihui Guo ◽

Chao Wang ◽

Peiqi Tian ◽

...

Keyword(s):

Breast Cancer ◽

Lymph Node ◽

Cancer Patients ◽

Lymph Node Dissection ◽

Complete Response ◽

Breast Cancer Patients ◽

Node Dissection ◽

Supraclavicular Lymph Node

Prognostic factors associated with pathological complete response in early breast cancer patients undergoing neoadjuvant chemotherapy: The importance of Ki-67 and molecular subtype

Annals of Oncology ◽

10.1093/annonc/mdy270.230 ◽

2018 ◽

Vol 29 ◽

pp. viii75

Author(s):

B.L. Rapoport ◽

J.A. Barnard-Tidy ◽

T. Smit ◽

S.J. Nayler ◽

C.A. Benn

Keyword(s):

Breast Cancer ◽

Prognostic Factors ◽

Cancer Patients ◽

Molecular Subtype ◽

Complete Response ◽

Breast Cancer Patients ◽

Ki 67 ◽

Factors Associated

Pathological complete response to neoadjuvant systemic therapy in 789 early and locally advanced breast cancer patients: The Royal Marsden experience

Breast Cancer Research and Treatment ◽

10.1007/s10549-019-05444-0 ◽

2019 ◽

Vol 179 (1) ◽

pp. 101-111 ◽

Cited By ~ 2

Author(s):

Nicolò Matteo Luca Battisti ◽

Victoria True ◽

Narda Chaabouni ◽

Neha Chopra ◽

Karla Lee ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Cancer Patients ◽

Systemic Therapy ◽

Locally Advanced Breast Cancer ◽

Locally Advanced ◽

Complete Response ◽

Breast Cancer Patients ◽

Neoadjuvant Systemic Therapy

254P Different patterns of distant recurrence depending on the expression of hormone receptor in breast cancer patients with pathological complete response to neoadjuvant chemotherapy

Annals of Oncology ◽

10.1016/j.annonc.2020.08.063 ◽

2020 ◽

Vol 31 ◽

pp. S341

Author(s):

J. Ponce ◽

A. Rodriguez-Lescure ◽

S. Delgado ◽

H. Ballester ◽

M. Pastor-Valero ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Hormone Receptor ◽

Response To Neoadjuvant Chemotherapy

Complete Response ◽

Distant Recurrence ◽

Breast Cancer Patients ◽

Prognostic nomograms for predicting overall and cancer-specific survival in breast cancer patients not achieving pathological complete response after neoadjuvant chemotherapy

Annals of Oncology ◽

10.1093/annonc/mdy427.001 ◽

2018 ◽

Vol 29 ◽

pp. ix8

Author(s):

J. Lai ◽

Z. Pan ◽

H. Deng ◽

J. Peng ◽

P. Chen ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Complete Response ◽

Breast Cancer Patients ◽

Cancer Specific Survival

Multi-gene prognostic signatures and prediction of pathological complete response of ER-Positive HER2-negative breast cancer patients to neo-adjuvant chemotherapy

Annals of Oncology ◽

10.1093/annonc/mdz240.081 ◽

2019 ◽

Vol 30 ◽

pp. v86 ◽

Cited By ~ 1

Author(s):

C. Mazo ◽

S. Barron ◽

C. Mooney ◽

W.M. Gallagher

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Complete Response ◽

Breast Cancer Patients ◽

Er Positive ◽

Neo Adjuvant Chemotherapy

Different Pathological Complete Response Rates According to PAM50 Subtype in HER2+ Breast Cancer Patients Treated With Neoadjuvant Pertuzumab/Trastuzumab vs. Trastuzumab Plus Standard Chemotherapy: An Analysis of Real-World Data

Frontiers in Oncology ◽

10.3389/fonc.2019.01178 ◽

2019 ◽

Vol 9 ◽

Cited By ~ 1

Author(s):

Tamara Díaz-Redondo ◽

Rocio Lavado-Valenzuela ◽

Begoña Jimenez ◽

Tomas Pascual ◽

Fernando Gálvez ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Real World ◽

Complete Response ◽

Breast Cancer Patients ◽

Standard Chemotherapy ◽

Real World Data ◽

Her2 Breast Cancer ◽

Pam50 Subtype

MRI in diagnosis of pathological complete response in breast cancer patients after neoadjuvant chemotherapy

European Journal of Radiology ◽

10.1016/j.ejrad.2014.11.029 ◽

2015 ◽

Vol 84 (2) ◽

pp. 242-249 ◽

Cited By ~ 4

Author(s):

Yan-Ling Li ◽

Xiao-Peng Zhang ◽

Jie Li ◽

Kun Cao ◽

Yong Cui ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Complete Response ◽

Breast Cancer Patients

The effect of obesity on pathological complete response and survival in breast cancer patients receiving uncapped doses of neoadjuvant anthracycline-taxane-based chemotherapy

The Breast ◽

10.1016/j.breast.2017.04.001 ◽

2017 ◽

Vol 33 ◽

pp. 153-158 ◽

Cited By ~ 10

Author(s):

Alex Farr ◽

Myriam Stolz ◽

Lukas Baumann ◽

Zsuzsanna Bago-Horvath ◽

Elisabeth Oppolzer ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Complete Response ◽

Breast Cancer Patients